Questão 1
Questão
What’s the most common type of heart disease, and leading cause of death?
Questão 2
Questão
There are two major categories of stroke. 80% are which one?
Questão 3
Questão
Platelets are disc-shaped fragments produced by __________.
Responda
-
Megakaryotes
-
Megakaryocytes
-
Minikaryocytes
-
Minikaryotes
-
Spleen
-
Blasts
Questão 4
Questão
Average platelet count is:
Responda
-
150,000 – 400,000 / μL
-
150 – 400 / μL
-
1,500 – 4,000 / μL
-
15,000 – 40,000 / μL
-
150,000 – 40,000 / μL
Questão 5
Questão
Which of the following are functional responses of platelets?
Responda
-
Primary adhesion
-
Shape change
-
Aggregation
-
Granule release
-
Procoagulant function
-
Anticoagulant function
-
Secondary adhesion
-
Antiapoptotic function
-
Proapoptotic function
-
Carry Oxygen
Questão 6
Questão
Shape change is a crucial functional response of platelets to …something. They change shape from [blank_start]__________[blank_end] to [blank_start]__________[blank_end]
Responda
-
Flat disc
-
Spiny disc
-
Spiny sphere
-
Smooth sphere
Questão 7
Questão
Which receptor/ligand interactions occur during which bit?
Responda
-
GPIb/V/IX – vWF
-
αIibβ3 – fibronectin, VWF
-
αIibβ3 – fibrinogen, fibronectin
-
GPIb/V/IX – vWF
-
αIibβ3 – fibronectin, VWF
-
αIibβ3 – fibrinogen, fibronectin
-
GPIb/V/IX – vWF
-
αIibβ3 – fibronectin, VWF
-
αIibβ3 – fibrinogen, fibronectin
Questão 8
Questão
Fibrin generation at the site of vascular injury has a crucial role in anchoring the thrombus to the vessel. It requires initiation of coagulation and generation of thrombin. This depends on Tissue Factor (TF) expression on the surface of [blank_start]__________[blank_end] and fibroblasts.
Responda
-
Smooth Muscle Cells (SMCs)
-
Vascular Endothelial Cells (VECs)
-
Vascular Epithelial Cells (VECs)
-
Skeletal Muscle Cells (SMCs)
-
Cardiac Muscle Cells (CMCs)
Questão 9
Questão
Platelet-mediated fibrin clot retraction shrinks the size of the blood clot. Thought to be important for stabilising the clot against shear forces of blood flow. This requires:
Responda
-
Integrin αIIbβ3
-
Fibrin
-
Myosin/contractile force
-
Actin cytoskeleton
Questão 10
Questão
Which of the following are prothrombotic and which are antithrombotic?
ADP: [blank_start]__________[blank_end];
Aspirin: [blank_start]__________[blank_end];
Epinephrine: [blank_start]__________[blank_end];
Clopidogrel: [blank_start]__________[blank_end];
Collagen: [blank_start]__________[blank_end];
Heparin: [blank_start]__________[blank_end];
Thrombin: [blank_start]__________[blank_end];
Responda
-
Pro
-
Anti
-
Anti
-
Pro
-
Pro
-
Anti
-
Anti
-
Pro
-
Pro
-
Anti
-
Anti
-
Pro
-
Pro
-
Anti
Questão 11
Questão
Does Aspirin prevent initial platelet adhesion?
Questão 12
Questão
Does Aspirin prolong skin bleeding time?
Questão 13
Questão
What’s the efficacy of Aspirin?
Responda
-
~5-10%
-
~15%
-
~25%
-
~30-50%
-
~50-70%
-
~75%
-
~85%
-
~90-95%
Questão 14
Questão
Does Aspirin inhibit prostacyclin synthesis?
Questão 15
Questão
Does Aspirin stimulate prostacyclin synthesis?
Questão 16
Questão
Does Aspirin suppress the release of thrombogenic factors from platelets?
Questão 17
Questão
Integrin αIibβ3 (GPIIbIIIa) inhibitors are:
Responda
-
Antithrombotic (but can cause severe bleeding)
-
Prothrombotic (but can cause severe bleeding)
-
Antithrombotic (but can't cause severe bleeding)
-
Prothrombotic (but can't cause severe bleeding)
Questão 18
Questão
Which of the following are CURRENT (not further potential) antithrombotic treatments:
Questão 19
Questão
PAR antagonists are under development as a potential novel antithrombotic. What’s PAR?
Responda
-
Protease-Activated Receptor
-
Protease-Antigen Receptor
-
Protease-Antagonist Receptor
-
Protease-Agonist Receptor
-
Protease-Activating Receptor